We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ultrahigh Resolution of 3D Human Brain Offered Free for Researchers

By LabMedica International staff writers
Posted on 03 Jul 2013
Print article
Image: The three-dimensional virtual brain is based on data from more than 7,400 tissue sections, each of them only 20 micrometers-thick, which were obtained from a human brain (Photo courtesy of werbefoto-burger.ch/Fotolia)
Image: The three-dimensional virtual brain is based on data from more than 7,400 tissue sections, each of them only 20 micrometers-thick, which were obtained from a human brain (Photo courtesy of werbefoto-burger.ch/Fotolia)
A milestone three-dimensional (3D) digital reconstruction of a complete human brain, called the BigBrain, for the first time reveals the brain anatomy in microscopic clarity at a spatial resolution of 20 micrometers, exceeding that of existing reference brains presently in the public domain.

The new application is made freely available to the broader scientific community to facilitate the exploration of the field of neuroscience. Researchers from Germany and Canada, who collaborated on the ultra-high resolution brain model, presented their project in the June 21, 2013, issue of the journal Science. “The authors pushed the limits of current technology,” said Science’s senior editor Peter Stern about the international scientific effort. “Such spatial resolution exceeds that of presently available reference brains by a factor of 50 in each of the three spatial dimensions.”

The sophisticated modern image processing technology reveal a never before seen look at the very fine specifics of the human brain’s microstructure (cellular level). The anatomic tool will allow for 3D cytoarchitectonic mapping of the human brain and act as an atlas for small cellular circuit data (single layers or sublayers of the cerebral cortex), explained the researchers.

Until recently, reference brains did not probe further than the macroscopic, or visible, components of the brain. Now, the BigBrain provides a resolution much finer than the typical 1 mm resolution from MRI studies.

The project “has been a tour-de-force to assemble images of over 7,400 individual histological sections, each with its own distortions, rips, and tears, into a coherent 3D volume,” said senior author Dr. Alan Evans, a professor at the Montreal Neurological Institute at McGill University (Montreal, QC, Canada). “This dataset allows for the first time a 3D exploration of human cytoarchitectural anatomy.”

Thin sections of a 65-year-old human female brain, which was embedded in paraffin wax, were cut with a special large-scale tool called a microtome. Then, the 20-micrometer-thick histologic sections were mounted on slides, stained to detect cell structures, and finally digitized with a high-resolution flatbed scanner so researchers could reconstruct the high-resolution 3D brain model. It took approximately 1,000 hours to gather the data. The final images revealed discrepancies in the laminar pattern between brain areas.
The new reference brain, which is part of the European Human Brain Project, serves as a powerful tool to advance neuroscience research and “redefines traditional maps from the beginning of the 20th century,” explained lead author Dr. Katrin Amunts from the Research Center Jülich and director of the Cecile and Oskar Vogt Institute for Brain Research at the Heinrich Heine University Düsseldorf (Germany). “The famous cytoarchitectural atlases of the early 1900s were simplified drawings of a brain and were based on pure visual analysis of cellular organization patterns,” added Dr. Amunts.

Because of the ernormous volume of this dataset, the researchers noted that there will be a drive by those who want to use it to develop new and helpful applications for visualization, data management, and analysis. “We plan to repeat this process in a sample of brains so that we can quantify cytoarchitectural variability,” said Dr. Evans. “We will also integrate this dataset with high-resolution maps of white matter connectivity in postmortem brains. This will allow us to explore the relationship between cortical microanatomy and fiber connectivity,” said Dr. Amunts.

“We are planning to integrate our receptor data of the human brain in the reference frame provided by the BigBrain,” continued senior coauthor Dr. Karl Zilles, who is senior professor of the Jülich Aachen Research Alliance and former director of the Cecile and Oskar Vogt Institute for Brain Research at the Heinrich Heine University Düsseldorf (Germany). “We will also transfer high-resolution maps of quantitative data on the regional and laminar distribution of native receptor complexes to the BigBrain. This will allow us to explore the relationship between cortical microanatomy and key molecules of neurotransmission.”

The extremely detailed anatomic resolution will allow scientists to gather clues into the neurobiologic foundation of cognition, language, emotions, and other processes, according to the study. The researchers in addition plan to extract measurements of cortical thickness to gain insights into better understanding aging and neurodegenerative disorders; create cortical thickness maps to compare data from in vivo imaging; incorporate gene expression data from the Allen Institute for Brain Science (Seattle, WA, USA); and generate a brain model with a resolution of 1 micrometer to capture details of single cell morphology.

Public access of the BigBrain dataset will be provided through the McGill’s CBRAIN Portal, with free registration, according to the researchers.

Related Links:

Montreal Neurological Institute at McGill University
Heinrich Heine University Düsseldorf
CBRAIN Portal


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The AI-based method can more accurately detect antibiotic resistance in deadly bacteria such as tuberculosis and staph (Photo courtesy of Adobe Stock)

New AI-Based Method Improves Diagnosis of Drug-Resistant Infections

Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.